IN2015DN02513A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN02513A IN2015DN02513A IN2513DEN2015A IN2015DN02513A IN 2015DN02513 A IN2015DN02513 A IN 2015DN02513A IN 2513DEN2015 A IN2513DEN2015 A IN 2513DEN2015A IN 2015DN02513 A IN2015DN02513 A IN 2015DN02513A
- Authority
- IN
- India
- Prior art keywords
- preparation
- compounds
- antibiotics
- ertapenem
- intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
- C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
The present invention relates to the preparation of compounds, in particular to the preparation of compounds which may be used as intermediates for the preparation of antibiotics , preferably carbapenem antibiotics more preferably ertapenem , and salts thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12188351 | 2012-10-12 | ||
PCT/EP2013/071252 WO2014057079A1 (en) | 2012-10-12 | 2013-10-11 | Preparation of ertapenem intermediates |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN02513A true IN2015DN02513A (en) | 2015-09-11 |
Family
ID=47022553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2513DEN2015 IN2015DN02513A (en) | 2012-10-12 | 2013-10-11 |
Country Status (9)
Country | Link |
---|---|
US (2) | US9546171B2 (en) |
EP (1) | EP2906561A1 (en) |
JP (1) | JP2015533142A (en) |
KR (1) | KR20150065176A (en) |
CN (1) | CN104703986A (en) |
AU (1) | AU2013328585A1 (en) |
CA (1) | CA2887098A1 (en) |
IN (1) | IN2015DN02513A (en) |
WO (1) | WO2014057079A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104703986A (en) * | 2012-10-12 | 2015-06-10 | 桑多斯股份公司 | Preparation of Ertapenem intermediates |
CN113880839A (en) * | 2021-11-01 | 2022-01-04 | 石药集团中诺药业(石家庄)有限公司 | Novel synthesis method of ertapenem sodium crude product |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9202298D0 (en) | 1992-02-04 | 1992-03-18 | Ici Plc | Antibiotic compounds |
TW513430B (en) | 1996-07-12 | 2002-12-11 | Merck & Co Inc | Process for synthesizing carbapenem antibiotics |
KR100364339B1 (en) | 1997-06-16 | 2002-12-18 | 머크 앤드 캄파니 인코포레이티드 | Stabilized carbapenem intermediates and synthetic use |
US5872250A (en) * | 1997-07-30 | 1999-02-16 | Merck & Co., Inc. | Process for synthesizing carbapenem antibiotics |
CA2457642C (en) | 2001-09-26 | 2009-01-06 | Merck & Co., Inc. | Crystalline forms of ertapenem sodium |
CN100457760C (en) * | 2005-10-20 | 2009-02-04 | 上海交通大学 | Preparation method of ertabeinan sodium salt |
US8293894B2 (en) | 2006-11-20 | 2012-10-23 | Orchid Chemicals & Pharmaceuticals Limited | Process for the preparation of carbapenem antibiotic |
KR101694506B1 (en) * | 2009-04-30 | 2017-01-10 | 씨에스피씨 종콰이 팔마씨우티컬 테크놀로지 (스자좡) 컴퍼니 리미티드 | Intermediates of ertapenem, compositions containing them and preparation methods thereof |
US8729260B2 (en) * | 2010-05-19 | 2014-05-20 | Savior Lifetec Corporation | Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem |
US20110288289A1 (en) * | 2010-05-19 | 2011-11-24 | Savior Lifetec Corporation | Preparation of Carbapenem Intermediate and Their Use |
KR20120007331A (en) | 2010-07-14 | 2012-01-20 | 주식회사 경보제약 | An improved process for the preparation of carbapenem compounds |
CN101935321A (en) * | 2010-07-20 | 2011-01-05 | 深圳市海滨制药有限公司 | Method for synthesizing 1 beta methyl carbapenem antibiotic |
CN102731502B (en) | 2011-04-13 | 2016-08-03 | 石药集团中奇制药技术(石家庄)有限公司 | A kind of preparation method of carbapenem antibiotics |
CN102351861A (en) * | 2011-08-16 | 2012-02-15 | 湖南欧亚生物有限公司 | Industrial preparation method of ertapenem |
CN102432611B (en) * | 2011-11-09 | 2013-11-20 | 上海希迈医药科技有限公司 | Dual-protection ertapenem crystal and preparation method thereof |
CN102731508A (en) * | 2012-07-03 | 2012-10-17 | 浙江海翔川南药业有限公司 | Crystal ertapenem intermediate as well as preparation method and application thereof |
CN104703986A (en) * | 2012-10-12 | 2015-06-10 | 桑多斯股份公司 | Preparation of Ertapenem intermediates |
-
2013
- 2013-10-11 CN CN201380053067.5A patent/CN104703986A/en active Pending
- 2013-10-11 WO PCT/EP2013/071252 patent/WO2014057079A1/en active Application Filing
- 2013-10-11 AU AU2013328585A patent/AU2013328585A1/en not_active Abandoned
- 2013-10-11 US US14/434,550 patent/US9546171B2/en not_active Expired - Fee Related
- 2013-10-11 EP EP13774444.7A patent/EP2906561A1/en not_active Withdrawn
- 2013-10-11 JP JP2015536143A patent/JP2015533142A/en active Pending
- 2013-10-11 KR KR1020157009049A patent/KR20150065176A/en not_active Application Discontinuation
- 2013-10-11 CA CA2887098A patent/CA2887098A1/en not_active Abandoned
- 2013-10-11 IN IN2513DEN2015 patent/IN2015DN02513A/en unknown
-
2017
- 2017-01-17 US US15/407,741 patent/US20170166570A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2887098A1 (en) | 2014-04-17 |
AU2013328585A1 (en) | 2015-04-09 |
CN104703986A (en) | 2015-06-10 |
JP2015533142A (en) | 2015-11-19 |
US9546171B2 (en) | 2017-01-17 |
US20170166570A1 (en) | 2017-06-15 |
US20150274732A1 (en) | 2015-10-01 |
WO2014057079A1 (en) | 2014-04-17 |
KR20150065176A (en) | 2015-06-12 |
EP2906561A1 (en) | 2015-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1207861A1 (en) | Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer bub1 | |
IL235944A0 (en) | Β-lactamase inhibitor compounds, compositions comprising same, methods of producing same and uses thereof | |
IL231591A0 (en) | Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. | |
ZA201308395B (en) | Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/orbace2 inhibitors | |
AU2012213775A8 (en) | 7-azaindole derivatives | |
AU2012265219A8 (en) | Compounds containing hydrido-tricyano-borate anions | |
PL2922893T3 (en) | Moisture-curing compositions, processes for producing same and use of same | |
EP2729464B8 (en) | Cyclopropyl-fused-1,3-thiazepines as bace 1 and/or bace 2 inhibitors | |
IN2014CN04050A (en) | ||
CA2875305C (en) | Fbxo3 inhibitors | |
HK1199024A1 (en) | Novel morpholinyl derivatives useful as mogat-2 inhibitors mogat-2 | |
EP3082823A4 (en) | Iminothiadiazepane dioxide compounds as bace inhibitors, compositions, and their use | |
WO2013155338A3 (en) | Substituted benzamides and their uses | |
PH12015500061A1 (en) | Method for preparing substituted triazolopyridines | |
GB201107985D0 (en) | Process | |
UA117567C2 (en) | Galactagogue compositions based on phosphatidylserine | |
AU2013347232A8 (en) | 3-Aminocyclopentane carboxamide derivatives | |
HK1207079A1 (en) | An improved process for the preparation of carbapenem antibiotic | |
IN2015DN02513A (en) | ||
UA72478U (en) | Use of polentar as frigoprotector | |
UA80618U (en) | Use of n-steroylethanolamine as radiomodifier | |
MY168958A (en) | Intermediates and processes for preparing compounds | |
EP2903586B8 (en) | Composition | |
IN2013CH00453A (en) | ||
AU2012903414A0 (en) | Composition |